Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.
Lightcast Discovery has raised $27.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Lightcast Discovery's investors include ARCH Venture Partners, Illumina Ventures, +ND Capital, OMX Ventures, Longwall Venture.
Lightcast Discovery is headquartered in Cambridge, United Kingdom.
Lightcast uses a microfluidic platform to make advances towards unique clinical approaches, new therapies, and innovative products.
Lightcast Discovery is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Lightcast Discovery — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/lightcast-discovery. Accessed July 20, 2026.
VCBacked. (2026). Lightcast Discovery — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/lightcast-discovery
{{cite web |title=Lightcast Discovery — Funding & Investors |url=https://www.vcbacked.co/company/lightcast-discovery |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated